Plain-English translation of NCT06101888 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the TaurusTrio™ Heart Valve System, a new device designed to repair or replace a leaky aortic valve without requiring open-heart surgery. Instead of traditional surgery, doctors insert this valve through a catheter (a thin tube) and guide it into place. The study wants to confirm that this treatment is safe and effective for people with severe aortic valve leakage who cannot or should not have conventional surgery.
Severe aortic valve leakage can cause serious heart problems and shortness of breath, but many patients are too weak or have too many other health conditions to undergo traditional open-heart surgery. This trial exists to see if this less invasive valve system can help these high-risk patients safely.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo the valve implant procedure at a participating hospital. Doctors will use imaging to guide a catheter through your blood vessels to your aortic valve, where they will position and deploy the new valve system. After the procedure, you will have follow-up visits and heart imaging tests to monitor how well the new valve is working and watch for any side effects over time.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China